Celerion Expands Belfast Facility

Celerion has added a containment room at the Belfast, Northern Ireland facility that will allow the company to develop programs that require studies using biologics and vaccines with primary and secondary containment. The containment room is a modular facility with a negative pressure processing room that houses a Biosafety Level (BSL-2) cabinet, enabling the processing of live class 2 and class 3 biologics.
 
“The addition of the containment room, coupled with our ability in the Belfast clinic to recruit large numbers of study participants, places Celerion in a strong position to conduct studies requiring biologics and vaccines,” said Phil Bach, vice president of Global Clinical Research at Celerion. “This announcement builds on the recent addition of the Bronchoscopy Suite and expansion of our services in the respiratory therapeutic area. The Belfast clinic is widely recognized as the Respiratory Centre of Excellence with experience in asthma, COPD, cystic fibrosis, and bronchiectasis clinical research.”